MR-guided radiation boost for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether giving a higher dose of radiation to the main tumor, guided by MRI scans, can improve treatment for a type of esophageal cancer called squamous cell carcinoma. You would first receive standard chemoradiation followed by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have squamous cell carcinoma of the esophagus or gastroesophageal junction (Siewert type I or II).
- Your tumor is considered locally advanced but can be removed with surgery (stages cT2-3, N0-3, M0).
- You are scheduled to receive chemoradiation (carboplatin, paclitaxel, and 41.4 Gy radiation) followed by surgery.
- Your tumor is 10 cm or shorter.
- You are 18 years or older and have a good performance status (WHO 0-2).
- You are able to have an MRI scan without any contraindications (like certain metal implants or claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation and immunotherapy for people with advanced esophageal cancer that cannot be surgically removed. The goal is to see if this approach is safe and effective after initial treatment.
This trial tests whether adding radiation therapy after initial chemoimmunotherapy improves outcomes for people with locally advanced esophageal cancer. It is designed for patients whose tumors are still responding or stable after the first treatment.
This trial tests whether adding two immunotherapy drugs to standard chemotherapy and radiation before surgery can help shrink esophageal cancer and improve outcomes. It is for people with a certain type of esophageal cancer that can be removed with surgery.
This trial tests whether a combination of low-dose radiation and immunotherapy can shrink advanced esophageal cancer enough to make it removable by surgery. It is for people whose cancer is considered borderline resectable or unresectable due to its location or spread.
This trial tests combining chemotherapy (FLOT) with a special type of MRI-guided radiation before surgery for esophageal adenocarcinoma. It aims to improve treatment results for patients with a specific type and stage of the disease.
This trial tests a personalized approach using MRI guidance for chemoradiotherapy combined with immunotherapy for limited advanced esophageal squamous cell cancer that cannot be surgically removed or has spread only to nearby lymph nodes. It aims to improve treatment effectiveness while reducing side effects.
Hear when a new Esophageal Squamous Cell Carcinoma (ESCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.